Yongsheng Jia, Ning Lu, Lihong He, Yehui Shi, Zhongsheng Tong. "Efficacy and safety of dalpiciclib plus toremifene in advanced HR-positive HER2-negative breast cancer as first-line treatment: A multicenter, single-arm phase II trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e13062